12:00 AM
 | 
Feb 28, 2000
 |  BC Week In Review  |  Company News  |  Deals

Kinetix, Dana-Farber Cancer Institute deal

The partners will evaluate the potential of small molecules to treat prostate cancer by inhibiting Akt, a...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >